Highlights

04-15 European Stocks Track Mostly Lower in Wednesday Trading MT
04-15 Traders weigh war deadlock; luxury woes hit Paris AN
04-15 GSK plc Receives Additional Marketing Approval for Depemokimab CI
04-15 Wall Street: Still Cautious, Still Buying Zonebourse
04-15 GSK Completes $950 Million Acquisition of 35Pharma to Boost Pulmonary Hypertension Pipeline MT
04-15 GSK plc completed the acquisition of 35Pharma Inc. CI
04-15 GSK completes purchase of Canada's 35Pharma for USD950 million AN
04-15 GSK Concludes $950 Million Acquisition of Canada's 35Pharma MT
04-15 "Double Down", Come What May Zonebourse
04-14 Betting on Restraint Zonebourse
04-14 The V for victory, at least on the charts Zonebourse
04-13 LIXTE Biotechnology Holdings, Inc. Presents Favorable Results For LB-100 And Dostarlimab Combination In Ovarian Cancer Study CI
04-13 Earnings Season in Trump's Shadow Zonebourse
04-13 GSK plc Presents Positive Data for B7-H4-Targeted ADC in Gynaecological Cancers CI
04-13 Bioversys Ag Publishes Pre-Clinical Data of Alpe Drug Combination in Nature Communications CI
04-13 Washington raises the stakes Zonebourse
04-13 UK Stocks-Factors to watch on April 13 RE
04-13 PRESS DIGEST-Financial Times - April 13 RE
04-10 European Stocks Tracking Higher in Friday Trading Amid US-Iran Ceasefire Talks; German Inflation Rises in March MT
04-10 Wall Street Gets a CPI Lifeline Zonebourse
04-10 US FDA Withdraws Approval for GSK's Wellcovorin Autism Use Application MT
04-09 U.S. FDA withdraws GSK's approval of Wellcovorin - Bloomberg news RE
04-09 GSK Plc Receives Approval For Exdensur (Depemokimab) In China For Treatment Of Chronic Rhinosinusitis With Nasal Polyps CI
04-09 Wall Street Rethinks the Rally Zonebourse
04-08 UK Shares Surge on US-Iran Ceasefire; Shell Falls MT
No results for this search